Literature DB >> 10325906

Treatment of pulmonary hypertension secondary to connective tissue diseases.

O Sanchez1, M Humbert, O Sitbon, G Simonneau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10325906      PMCID： PMC1745447          DOI： 10.1136/thx.54.3.273

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  53 in total

1.  Lupus cor pulmonale with electron microscope and immunofluroescent antibody studies.

Authors:  P P Yeo; R Sinniah
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

2.  Disseminated immune deposits in lupus erythematosus.

Authors:  J Brentjens; E Ossi; B Albini; M Sepulveda; K Kano; J Sheffer; P Vasilion; E Marine; T Baliah; H Jockin; G Andres
Journal:  Arthritis Rheum       Date:  1977-05

3.  Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease.

Authors:  B A Reitz; J L Wallwork; S A Hunt; J L Pennock; M E Billingham; P E Oyer; E B Stinson; N E Shumway
Journal:  N Engl J Med       Date:  1982-03-11       Impact factor: 91.245

4.  Nifedipine treatment for pulmonary hypertension in a patient with systemic sclerosis.

Authors:  S Ocken; E Reinitz; J Strom
Journal:  Arthritis Rheum       Date:  1983-06

5.  Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.

Authors:  L J Rubin; B M Groves; J T Reeves; M Frosolono; F Handel; A E Cato
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

6.  A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.

Authors:  W D Sullivan; D J Hurst; C E Harmon; J H Esther; G A Agia; J D Maltby; S B Lillard; C N Held; J F Wolfe; E V Sunderrajan
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

7.  Pulmonary hypertension in polymyositis.

Authors:  T W Bunch; R G Tancredi; J T Lie
Journal:  Chest       Date:  1981-01       Impact factor: 9.410

8.  Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis.

Authors:  R G Ungerer; D P Tashkin; D Furst; P J Clements; H Gong; M Bein; J W Smith; N Roberts; W Cabeen
Journal:  Am J Med       Date:  1983-07       Impact factor: 4.965

9.  Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease.

Authors:  A P Niarchos; H H Whitman; J E Goldstein; J H Laragh
Journal:  Am Heart J       Date:  1982-10       Impact factor: 4.749

Review 10.  Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature.

Authors:  H D Perez; N Kramer
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532
View more
  17 in total

Review 1.  A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.

Authors:  E Hachulla; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

2.  Pulmonary hypertension in a patient with adult-onset Stills disease.

Authors:  Eisha Mubashir; M Mubashir Ahmed; Samina Hayat; Maureen Heldmann; Seth Mark Berney
Journal:  Clin Rheumatol       Date:  2006-07-27       Impact factor: 2.980

3.  Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension.

Authors:  Rennie L Rhee; Nicole B Gabler; Sapna Sangani; Amy Praestgaard; Peter A Merkel; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2015-11-01       Impact factor: 21.405

Review 4.  Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis.

Authors:  Tian-Tian Lv; Peng Wang; Shi-Yang Guan; Hong-Miao Li; Xiao-Mei Li; Bin Wang; Hai-Feng Pan
Journal:  Ir J Med Sci       Date:  2017-12-18       Impact factor: 1.568

5.  Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension.

Authors:  Wei Wang; Yu-Lin Wang; Xiao-Ying Chen; Yu-Tang Li; Wei Hao; You-Peng Jin; Bo Han
Journal:  Mol Biol Rep       Date:  2011-03-23       Impact factor: 2.316

Review 6.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

7.  Severe Pulmonary Hypertension in Primary Sjögren's Syndrome.

Authors:  Ji-An Hwang; Tae-Hyun Yang; Ji-Young Lee; Dong-Wan Koo; In Suk Choi; Sun-Young Cho; Min-Sung Kim
Journal:  Korean Circ J       Date:  2013-07-31       Impact factor: 3.243

8.  Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.

Authors:  Son-Mi Chung; Chang-Keun Lee; Eun Young Lee; Bin Yoo; Sang-Do Lee; Hee-Bom Moon
Journal:  Clin Rheumatol       Date:  2006-02-22       Impact factor: 2.980

9.  Sildenafil Reduces Inflammation and Prevents Pulmonary Arterial Remodeling of the Monocrotaline - induced Disease in the Wistar Rats.

Authors:  Stefan Bogdan; Andrei Seferian; Andreea Totoescu; Stefan Dumitrache-Rujinski; Mihai Ceausu; Cristin Coman; Carmen-Maria Ardelean; Maria Dorobantu; Miron Bogdan
Journal:  Maedica (Buchar)       Date:  2012-06

10.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Authors:  D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.